Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has issued an update.
Clarity Pharmaceuticals Ltd. has announced a change in the substantial holding of its securities, indicating a shift in the ownership structure. This change involves State Street Corporation and its subsidiaries, which have ceased to be substantial holders. The announcement may impact the company’s market perception and investor relations as it reflects alterations in the voting interests and potential strategic direction.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$8.20 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,098,329
Technical Sentiment Signal: Buy
Current Market Cap: A$1.4B
See more data about CU6 stock on TipRanks’ Stock Analysis page.